Abstract The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …

The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes the
coronavirus disease 2019 (COVID-19) has significantly altered people's way of life. Despite …

The repeat emergence of SARS-CoV-2 variants of concern (VoC) with decreased
susceptibility to vaccine-elicited antibodies highlights the need to develop next-generation …

The emergence of the highly contagious Omicron variant of SARS-CoV-2 has inflicted
significant damage during the ongoing COVID-19 pandemic. This new variant's significant …

The COVID-19 pandemic has significantly impacted human health for three years. To
mitigate the spread of SARS-CoV-2, the development of neutralizing antibodies has been …

As the world continues to grapple with infectious diseases, scientists are constantly
searching for effective ways to combat these deadly pathogens. One promising avenue of …

Antibodies represent a relatively mature detection means and serve as therapeutic drug
carriers in the clinical diagnosis and treatment of cancer—among which monoclonal …

Immunocompromised patients often fail to raise protective vaccine-induced immunity against
the global emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Nanobodies, single-domain antibodies derived from variable domain of camelid or shark
heavy-chain antibodies, have unique properties with small size, strong binding affinity, easy …

The aim of this review is to summarize some of the most recent work in the field of
cardiovascular disease (CVD) diagnosis and therapy, focusing mainly on the role of …